secosteroids - CISMeF

Preferred Label : secosteroids;

MeSH definition : Steroids in which fission of one or more ring structures and concomitant addition of a hydrogen atom at each terminal group has occurred.;

Wikipedia automatic translation : Secosteroid;

Wikipedia link : https://en.wikipedia.org/wiki/Secosteroid;

Is substance : O;

Details

Origin ID

D012632;

UMLS CUI

C0036532;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- 4,5-secodihydrotestosterone [MeSH Supplementary Concept]
Record concept(s)
- secosteroids [MeSH concept]
Related MeSH Supplementary Concept(s)
- 11-acetoxy-24-methyl-3,5,6-trihydroxy-9,11-secocholest-7-en-9-one [MeSH Supplementary Concept]
- 13-ethyl-3-methoxy-8,14-secogona-1,3,5(10),9(11)-tetraene-14,17-dione [MeSH Supplementary Concept]
- 14,15-secocholestane [MeSH Supplementary Concept]
- 14,15-secoestra-1,3,5(10)-trien-15-yne-3,17-diol [MeSH Supplementary Concept]
- 17-hydroxy-14,15-secoandrost-4-en-15-yn-3-one [MeSH Supplementary Concept]
- 17-hydroxy-3-methoxy-17-phenyl-16,17-secoestra-1,3,5(10)-triene-16-nitrile [MeSH Supplementary Concept]
- 2,3-secocholestan-2,3-dioic acid [MeSH Supplementary Concept]
- 2,3-secocholestane-2,3-diol [MeSH Supplementary Concept]
- 20-oxopregnacalciferol [MeSH Supplementary Concept]
- 23-oxo-3,4-seco-lanosta-4(28),7(8),9(11),24(31)-tetraene-3,26-dicarboxylic acid [MeSH Supplementary Concept]
- 24-nor-9,11-seco-11-acetoxy-3,6-dihydroxycholesta-7,22-dien-9-one [MeSH Supplementary Concept]
- 24-nor-9,11-seco-11-oxo-3,6-dihydroxycholesta-7,22-dien-9-one [MeSH Supplementary Concept]
- 3,11-dihydroxy-5,6-epoxy-24-methyl-9,11-secocholestan-9-one [MeSH Supplementary Concept]
- 3,12-dihydroxy-9(10)-secoandrosta-1,3,5(10)-triene-9,17-dione [MeSH Supplementary Concept]
- 3,4,7,12-tetrahydroxy-9,10-seco-1,3,5(10)-androstatriene-9,17-dione [MeSH Supplementary Concept]
- 3,4-dihydroxy-9,10-secoandrosta-1,3,5,7-tetraene-9,17-dione [MeSH Supplementary Concept]
- 3,5-seco-4-norcholestan-5-one oxime-3-ol [MeSH Supplementary Concept]
- 3,7,11-trihydroxy-5,6-epoxy-9,11-secogorgostan-9-one [MeSH Supplementary Concept]
- 3,7-dihydroxy-5,9,17-trioxo-4(5),9(10)-disecoandrosta-1(10)2-dien-4-oic acid [MeSH Supplementary Concept]
- 3-hydroxy-13-amino-13,17-secoandrostan-17-oic-13,17-lactam p-bis(2-chloroethyl)amino phenyl acetate [MeSH Supplementary Concept]
- 3-hydroxy-14,15-secoestra-1,3,5(10)-trien-15-yn-17-one [MeSH Supplementary Concept]
- 3-hydroxy-17-(2-((2-(N,N-dimethylamino)ethoxy)imino)ethyl)-14,15-secoandrostan-14-one [MeSH Supplementary Concept]
- 3-hydroxy-5-oxo-5,6-secocholestan-6-al [MeSH Supplementary Concept]
- 3-methoxy-17-oxo-17-phenyl-16,17-secoestra-1,3,5(10)-triene-16-nitrile [MeSH Supplementary Concept]
- 3alpha-methoxy-2,3-dihydro-4,7-didehydrophysalin B [MeSH Supplementary Concept]
- 3beta,5alpha,6beta,11-tetrahydroxy-9,11-secocholest-7-en-9-one [MeSH Supplementary Concept]
- 3beta,6beta,11-trihydroxy-9,11-seco-5alpha-cholest-7-en-9-one [MeSH Supplementary Concept]
- 4,5-allenic-3 beta-hydroxy-5,10-secosteroid [MeSH Supplementary Concept]
- 4,5-secocholestane [MeSH Supplementary Concept]
- 4-methyl-2,3-secocholestane-2,3-diol [MeSH Supplementary Concept]
- 4-methyl-4,5-secocholestane [MeSH Supplementary Concept]
- 4a,17-dimethyl-A-homo-B,19-dinor-3,4-secoandrost-9-ene-3,17-diol [MeSH Supplementary Concept]
- 5-(2-(1-(1-(3-ethyl-3-hydroxypentyloxy)ethyl)-7-methyldihydro-1H-inden-4(2H,5H,6H,7H,7alphaH)-ylidene)ethylidene)-2-methylenecyclohexane-1,3-diol [MeSH Supplementary Concept]
- 6-(2-(1-(1-(3-ethyl-3-hydroxypentyloxy)ethyl)-7-methyldihydro-1H-inden-4(2H,5H,6H,7H,7alphaH)-ylidene)ethylidene)spiro(2.5)octane-4,8-diol [MeSH Supplementary Concept]
- 8H-3,11-dihydroxy-5,6-expoxy-24-methylene-9,11-secocholestan-9-one [MeSH Supplementary Concept]
- 9,11-seco-3,6,11-trihydroxy-24-methylenecholest-7-en-9-one [MeSH Supplementary Concept]
- 9,11-seco-3,6,11-trihydroxycholest-7-en-9-one [MeSH Supplementary Concept]
- aplysiasecosterol A [MeSH Supplementary Concept]
- calicoferol B [MeSH Supplementary Concept]
- calicoferol C [MeSH Supplementary Concept]
- calicoferol D [MeSH Supplementary Concept]
- calicoferol E [MeSH Supplementary Concept]
- cynatratoside-C [MeSH Supplementary Concept]
- doisynolic acid [MeSH Supplementary Concept]
- hancogenin B [MeSH Supplementary Concept]
- isophysalin A [MeSH Supplementary Concept]
- luffasterol A [MeSH Supplementary Concept]
- luffasterol B [MeSH Supplementary Concept]
- luffasterol C [MeSH Supplementary Concept]
- macrocoussaric acid A [MeSH Supplementary Concept]
- macrocoussaric acid B [MeSH Supplementary Concept]
- malaitasterol A [MeSH Supplementary Concept]
- methyl 3-bromomethyl-1-cyano-3-oxo-2,3-seco-2-norlup-20(29)-en-30-al-28-oate [MeSH Supplementary Concept]
- methyl 3-hydroxy-9-oxo-9,10-seco-23,24-dinor-1,3,5(10)-cholatrienoate [MeSH Supplementary Concept]
- pachyclavulariaenone B [MeSH Supplementary Concept]
- physalin B [MeSH Supplementary Concept]
- physalin D [MeSH Supplementary Concept]
- physalin E [MeSH Supplementary Concept]
- physalin F [MeSH Supplementary Concept]
- physalin G [MeSH Supplementary Concept]
- physalin H [MeSH Supplementary Concept]
- physalin L [MeSH Supplementary Concept]
- physalin O [MeSH Supplementary Concept]
- physalin T [MeSH Supplementary Concept]
- sarocladione [MeSH Supplementary Concept]
- sinularoside A [MeSH Supplementary Concept]
- sinularoside B [MeSH Supplementary Concept]
- tylophoriside A [MeSH Supplementary Concept]
- tylophoroside [MeSH Supplementary Concept]
- tylopiol A [MeSH Supplementary Concept]
- tylopiol B [MeSH Supplementary Concept]
- urmiensic acid [MeSH Supplementary Concept]
- urmiensolide B [MeSH Supplementary Concept]
- withaphysalin C [MeSH Supplementary Concept]
- withaphysalin F [MeSH Supplementary Concept]
- withaphysalin M [MeSH Supplementary Concept]
- withaphysalin N [MeSH Supplementary Concept]
- withaphysalin O [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients